Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Patupilone shows promise in the treatment of multiple myeloma

Feb. 9, 2005

Patent discloses new antimitotic agents for cancer

Feb. 8, 2005

Aurora kinase inhibitors developed at AstraZeneca

Feb. 8, 2005

Enzon to discontinue pegamotecan development

Feb. 8, 2005

Premarket approval for BioGenex' InSite Her-2/neu Kit

Feb. 8, 2005

New antimitotic agents in early development at SCRAS

Feb. 7, 2005

Progen plans new phase II study for PI-88 in combination with DTIC

Feb. 7, 2005

Velcade approved for use in Canada

Feb. 7, 2005

U. of South Florida isolates compound from tunicate for melanoma

Feb. 7, 2005

Antitumor properties of polyoxomolybdate PM-8 result from induction of apoptosis

Feb. 7, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...